EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow Alzheimer's in early stages
Disease control Recruiting nowThis study tests an experimental tablet called TTYP01 in 180 people with early Alzheimer's (mild memory problems or mild dementia). Participants are randomly assigned to one of two doses of TTYP01 or a placebo. The main goal is to see if the drug slows decline in thinking and dai…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThis study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Could this drug slow Alzheimer's brain damage?
Disease control Recruiting nowThis study tests an experimental drug called MK-2214 in 340 people with early Alzheimer's disease. The goal is to see if it can slow the buildup of a harmful protein called tau in the brain, which damages brain cells. Participants will receive either the drug or a placebo, and re…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC